• EZ Cap EGFP mRNA 5-moUTP: Streamlining High-Fidelity mRNA Wo

  2026-07-28

  EZ Cap™ EGFP mRNA (5-moUTP) enables robust, immune-evasive protein expression in both in vitro and in vivo settings. Its advanced chemical modifications and Cap 1 structure set a new benchmark for reproducibility, translation efficiency, and real-time imaging applications.

• Capsaicin as a Dual TRPV1 Agonist and KDM1A Inhibitor in Pai

  2026-07-28

  Explore the multifaceted role of Capsaicin in TRPV1 activation and KDM1A inhibition, with insights into its applications for pain and gastric cancer research. This article delivers a mechanistic, evidence-based analysis distinct from existing protocols and reviews.

• Z-DEVD-FMK (SKU A1920): Robust Caspase-3 Inhibition in Apopt

  2026-07-27

  This article explores real-world laboratory challenges in cell death research and demonstrates how Z-DEVD-FMK (SKU A1920) delivers reproducible, data-driven solutions for apoptosis assays and neuroprotection studies. Scenario-based Q&A blocks guide researchers through workflow optimization, protocol tuning, interpretative pitfalls, and vendor selection—anchoring recommendations in published evidence and APExBIO’s product quality.

• Pravastatin Sodium: Applied Protocols for HMG-CoA Reductase

  2026-07-27

  Pravastatin sodium stands out as a gold-standard HMG-CoA reductase inhibitor, enabling precise cholesterol biosynthesis inhibition across cellular and animal models. This article delivers advanced workflows, troubleshooting strategies, and practical insights grounded in the latest transporter and hepatocyte studies, highlighting APExBIO’s commitment to reagent quality and research reproducibility.

• Cy5 maleimide (non-sulfonated): Technical Use in Protein Lab

  2026-07-26

  Cy5 maleimide (non-sulfonated) enables site-specific fluorescent labeling of peptides and proteins via cysteine thiol groups, addressing selective probe conjugation for imaging, tracking, and assay workflows. It is not suitable for applications requiring high aqueous solubility or for targets lacking accessible thiols, and it demands careful workflow design to avoid common pitfalls.

• Tankyrase Inhibition Suppresses HCC Growth via Hippo Pathway

  2026-07-25

  Jia et al. (2017) demonstrate that tankyrase 1/2 inhibitors, including G007-LK, suppress hepatocellular carcinoma cell proliferation by modulating the Hippo-YAP signaling cascade. Their findings suggest a mechanistically distinct anti-tumor strategy, with practical implications for targeting both Wnt/β-catenin and Hippo pathway dysregulation in liver and potentially other cancers.

• Dutasteride in Prostate Research: Beyond Pathway Inhibition

  2026-07-24

  Explore Dutasteride as a dual 5-alpha-reductase inhibitor with advanced mechanistic insights for apoptosis induction in prostate cancer research. This article uniquely bridges molecular assay optimization and translational relevance, offering deeper guidance than standard protocol reviews.

• Clodronate Liposomes: Redefining Macrophage Depletion in Imm

  2026-07-24

  Explore how Clodronate Liposomes enable targeted in vivo macrophage depletion, advancing immune modulation beyond current protocols. This article uniquely connects mechanistic insight with translational assay design, providing practical strategies for next-generation immunotherapy studies.

• Isoprinosine in Immunotherapy: Protocols and Applied Insight

  2026-07-23

  Isoprinosine (inosine pranobex) empowers researchers to bridge direct viral inhibition with immune modulation, making it a standout choice for acute respiratory viral infection models and herpesvirus studies. This guide delivers actionable protocol tips, troubleshooting strategies, and workflow optimizations that leverage the latest mechanistic findings for robust, reproducible immunotherapy research.

• 3-Deazaadenosine Hydrochloride in m6A-Driven Liver Fibrosis

  2026-07-23

  Explore how 3-Deazaadenosine hydrochloride, a leading S-adenosylhomocysteine hydrolase inhibitor, is transforming m6A methylation studies in hepatic stellate cell activation and liver fibrosis. Discover advanced protocols and practical insights not found in standard guides.

• Abiraterone Acetate: CYP17 Inhibitor Workflows in Prostate C

  2026-07-22

  Harnessing Abiraterone acetate as a potent CYP17 inhibitor enables precise, reproducible androgen biosynthesis blockade in advanced prostate cancer models. Explore optimized workflows, troubleshooting insights, and translational applications that leverage this key molecule for both 2D and 3D research platforms.

• Gap19: Selective Connexin 43 Hemichannel Blocker for Neuropr

  2026-07-22

  Gap19 is a selective connexin 43 hemichannel blocker that enables precise inhibition of ATP release in astrocytes and offers robust neuroprotection in cerebral ischemia models. Its specificity spares gap junction channels, making it a benchmark tool for dissecting Cx43-mediated pathways. This article details its mechanism, evidence base, and practical research integration.

• HOXC8 Suppresses Pyroptosis in NSCLC by Regulating Caspase-1

  2026-07-21

  This study reveals that the transcription factor HOXC8 inhibits pyroptotic cell death in non-small cell lung carcinoma (NSCLC) by repressing caspase-1 expression through HDAC1/2 recruitment. The findings provide mechanistic insight into how HOXC8 modulates tumorigenesis and cell death pathways, highlighting new perspectives for research into immune and apoptotic signaling in cancer.

• Actinomycin D in Cancer Research: Workflows, Troubleshooting

  2026-07-21

  Actinomycin D (ActD) is a gold-standard transcriptional inhibitor with unique value for apoptosis induction and mRNA stability assays in cancer research. This guide translates recent biomarker advances and hands-on protocol optimizations into actionable steps, ensuring robust experimental outcomes.

• Regorafenib Suppresses Melanoma Progression via RRM2 Downreg

  2026-07-20

  This study demonstrates that Regorafenib (BAY 73-4506) limits melanoma cell proliferation, invasion, and metastasis by targeting RRM2 through the ERK/E2F3 signaling pathway. These findings highlight RRM2 as a pivotal downstream mediator and suggest new avenues for translational research in cancer biology.

16118 records 1/1075 page Next 12345 下5页 Last page